Evidence map›Paper›PMID 31885626›Full record

ArticleStem cells international2019

Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro.

Bishao Sun, Xing Luo, Chengfei Yang, Peilin Liu, Yang Yang, Xingyou Dong, Zhenxing Yang, Jie Xu, Yuanyuan Zhang, Longkun Li

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Stem cells international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Bishao SunDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.ORCID https://orcid.org/0000-0003-3962-5043
Xing LuoDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Chengfei YangDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Peilin LiuDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Yang YangDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.ORCID https://orcid.org/0000-0002-2046-3542
Xingyou DongDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Zhenxing YangDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Jie XuDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.ORCID https://orcid.org/0000-0001-6700-7096
Yuanyuan ZhangWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA.ORCID https://orcid.org/0000-0002-5708-9718
Longkun LiDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.ORCID https://orcid.org/0000-0003-3939-5647
Army Medical University · CNForest Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is an extremely dangerous clinical syndrome with high morbidity and mortality. Stem cell-based therapies have shown great promise for AKI treatment. Urine-derived stem cells (USCs) are a novel cell source in tissue engineering and cell therapy which provide advantages of simple, noninvasive, and low-cost harvest methods, efficient proliferation, and multi-differentiation potential. Here, we described the therapeutic effects of USCs in a rat model of cisplatin-induced AKI as a novel therapy. In vivo, the intravenous administration of USCs alleviated the renal functional damage in AKI rats, for the levels of blood urea nitrogen (BUN) and serum creatinine (SCr) were significantly decreased. The USCs-treated group also exhibited improved histological and ultrastructural changes, promoted proliferation, and inhibited apoptosis in renal tissues. After the USC therapy, the expression levels of proinflammatory cytokines (TNF-

Identifiers

PMID31885626
PMCPMC6893246
OpenAlexW2989620462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.